252 related articles for article (PubMed ID: 3105869)
1. Estrogen receptor binding to nuclei from normal and neoplastic rat mammary tissues in vitro.
Klinge CM; Bambara RA; Zain S; Hilf R
Cancer Res; 1987 Jun; 47(11):2852-9. PubMed ID: 3105869
[TBL] [Abstract][Full Text] [Related]
2. Effects of host hormonal status on binding of activated estrogen receptor to nuclei from R3230AC and 7,12-dimethylbenz[a]anthracene-induced mammary tumors.
Klinge CM; Bambara RA; Zain S; Hilf R
Cancer Res; 1989 Mar; 49(5):1165-70. PubMed ID: 2492902
[TBL] [Abstract][Full Text] [Related]
3. Nuclease sensitivity of estradiol-charged estrogen receptor binding sites in nuclei isolated from normal and neoplastic rat mammary tissues.
Klinge CM; Bambara RA; Zain S; Hilf R
J Steroid Biochem; 1990 Jun; 36(1-2):7-14. PubMed ID: 2194077
[TBL] [Abstract][Full Text] [Related]
4. Prolactin binding to mammary gland, 7,12-dimethylbenz(a)-anthracene-induced mammary tumors, and liver in rats.
Smith RD; Hilf R; Senior AE
Cancer Res; 1976 Oct; 36(10):3726-31. PubMed ID: 821605
[TBL] [Abstract][Full Text] [Related]
5. EGF receptors in R3230AC rat mammary carcinomas: characteristics and regulation in vitro and in vivo.
Ryan PD; Hilf R
Oncol Res; 1992; 4(4-5):181-92. PubMed ID: 1504378
[TBL] [Abstract][Full Text] [Related]
6. Steroid-binding proteins of the mammary gland and their clinical significance in breast cancer.
Wittliff JL; Mehta RG; Boyd PA; Goral JE
J Toxicol Environ Health Suppl; 1976; 1():231-56. PubMed ID: 186628
[TBL] [Abstract][Full Text] [Related]
7. Prolactin regulation of estrogen and progesterone receptors in normal and neoplastic mouse mammary tissue.
Koseki Y; Cole D; Matsuzawa A; Costlow ME
Jpn J Cancer Res; 1987 Oct; 78(10):1105-11. PubMed ID: 3119544
[TBL] [Abstract][Full Text] [Related]
8. Prolactin binding to dissociated cells from rat mammary tumors and mammary gland.
Smith RD; Hilf R; Senior AE
Cancer Biochem Biophys; 1979; 3(3):117-21. PubMed ID: 121922
[TBL] [Abstract][Full Text] [Related]
9. Antagonism of development and growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors by the antiestrogen U 23,469 and effects on estrogen and progesterone receptors.
Tsai TL; Katzenellenbogen BS
Cancer Res; 1977 May; 37(5):1537-43. PubMed ID: 404032
[TBL] [Abstract][Full Text] [Related]
10. Influence of prenatal exposure to diethylstilbestrol on estrogen and progestin binding proteins in uteri and dimethylbenzanthracene- induced mammary tumors of the rat.
Heidemann PH; Wittliff JL; Calhoon RE; Boylan ES
J Toxicol Environ Health; 1981 Oct; 8(4):667-86. PubMed ID: 6802985
[TBL] [Abstract][Full Text] [Related]
11. Regulation of estrogen-binding capacity by insulin in 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
Gibson SL; Hilf R
Cancer Res; 1980 Jul; 40(7):2343-8. PubMed ID: 6770998
[TBL] [Abstract][Full Text] [Related]
12. Antiestrogen(4-hydroxytamoxifen)-charged estrogen receptor binding to nuclei from normal and neoplastic rat mammary tissues is not affected by host hormonal status.
Klinge CM; Knox DT; Bambara RA; Zain S; Hilf R
J Steroid Biochem; 1989 Sep; 33(3):335-40. PubMed ID: 2779224
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of progesterone-binding components in neoplastic mammary tissues of the rat.
Goral JE; Wittliff JL
Cancer Res; 1976 Jun; 36(6):1886-93. PubMed ID: 178435
[TBL] [Abstract][Full Text] [Related]
14. Prolactin binding to R3230AC mammary carcinoma and liver in hormone-treated and diabetic rats.
Smith RD; Hilf R; Senior AE
Cancer Res; 1977 Feb; 37(2):595-8. PubMed ID: 188551
[TBL] [Abstract][Full Text] [Related]
15. An endogenous inhibitor of [3H]estradiol binding to nuclear type II estrogen binding sites in normal and malignant tissues.
Markaverich BM; Roberts RR; Alejandro MA; Clark JH
Cancer Res; 1984 Apr; 44(4):1515-9. PubMed ID: 6704964
[TBL] [Abstract][Full Text] [Related]
16. Steroid hormone receptor expression and proliferation in rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
Qiu C; Shan L; Yu M; Snyderwine EG
Carcinogenesis; 2005 Apr; 26(4):763-9. PubMed ID: 15637090
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a unique nuclear estrogen-binding component in an estrogen-responsive mouse Leydig cell tumor.
Maeda Y; Sato B; Noma K; Kishimoto S; Koizumi K; Aono T; Matsumoto K
Cancer Res; 1983 Sep; 43(9):4091-7. PubMed ID: 6871850
[TBL] [Abstract][Full Text] [Related]
18. Similarities and differences in the ultrastructure of two hormone-dependent and one independent human breast carcinoma grown in athymic nude mice: comparison with the rat DMBA-induced tumor and normal secretory mammocytes.
Anderson WA; Perotti ME; McManaway M; Lindsey S; Eckberg WR
J Submicrosc Cytol; 1984 Oct; 16(4):673-90. PubMed ID: 6438351
[TBL] [Abstract][Full Text] [Related]
19. [Comparative study of the interaction between different forms of estrogen receptors and cell nuclei].
Mataradze GD; Gontar' EV; Kondrat'ev IaIu; Rozen VB
Biokhimiia; 1982 May; 47(5):869-78. PubMed ID: 7093387
[TBL] [Abstract][Full Text] [Related]
20. Receptor characteristics of the rat mammary carcinoma cell line 64-24.
Eil C; Douglass EC; Rosenburg SM; Kano-Sueoka T
Cancer Res; 1981 Jan; 41(1):42-8. PubMed ID: 6256064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
